Clinical study protocol for the treatment of moderate to severe persistent allergic rhinitis with lung-deficiency-related cold type by fire acupuncture at the Inner Yingxiang(Ex-HN09) point

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2200006073

Enrollment

Unknown

Registered

2022-06-06

Start date

2022-07-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Interventions

sham fire acupuncture control group:sham fire acupuncture

western medicine control group:western medicine

fire acupuncture group:fire acupuncture

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meets the agnostic criteria for allergic rhinitis with lung-deficiency-related cold type. 2.Meets the diagnostic criteria for persistent allergic rhinitis with symptom onset = 4 d/week and = 4 consecutive weeks. 3.Meets the diagnostic criteria for moderate-to-severe allergic rhinitis with severe or serious symptoms that have a significant impact on the quality of life. 4.Age between 18 and 65 years old with a disease duration of = 1 year. 5.Voluntary completion of the informed consent form, agreeing to participate in the clinical subjects.

Exclusion criteria

Exclusion criteria: 1.Age 65 years. 2.Patients with combined sinusitis, upper respiratory tract infection or asthma. 3.Patients with known presence or suspected allergy to loratadine or contraindications to its use. 4.Have used antihistamines, oral or nasal spray glucocorticoids, decongestants, mast cell membrane stabilizers, leukotriene antagonists, etc. within 14 days. 5.Patients who have received specific immunotherapy or systemic glucocorticoid treatment within the last year. 6.Patients who have received traditional medical internal or external therapies such as acupuncture, moxibustion, tui na or oral Chinese medicine within the last 1 month for allergic rhinitis. 7.Combined with tumors, serious heart, liver, kidney and other vital organs, blood and endocrine diseases. 8.Pregnancy, pregnancy preparation, breastfeeding plan within the last six months. 9.Those who have not signed informed consent.

Design outcomes

Primary

Measure	Time frame
Total Nasal Symptom Score(TNSS);	—

Secondary

Measure	Time frame
Rhinoconjunctivitis Quality of Life Questionnaire(RQLQ);Allergic Rhinitis Control Test Questionnaire(ARCT);Total Non-nasal Symptom Score(TNNSS);rhinomanometry;	—

Countries

China

Contacts

Public ContactAi Jianwei

ajw3881@126.com18910277635

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026